J L Colli

Summary

Affiliation: University of Alabama at Birmingham
Country: USA

Publications

  1. ncbi Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America
    J L Colli
    Department of Urology, University of Alabama, Birmingham, AL 35294, USA
    Prostate Cancer Prostatic Dis 11:247-51. 2008
  2. ncbi Solar ultraviolet B radiation compared with prostate cancer incidence and mortality rates in United States
    Janet L Colli
    Department of Urology, University of Alabama, Birmingham, School of Medicine, Birmingham, Alabama 35294, USA
    Urology 71:531-5. 2008
  3. ncbi Exploring causes for declining prostate cancer mortality rates in the United States
    Janet L Colli
    Department of Urology, University of Alabama, Birmingham, AL 35294, USA Birmingham VA Medical Center VMAC, Birmingham, AL 35294, USA
    Urol Oncol 26:627-33. 2008
  4. ncbi High cholesterol levels are associated with reduced prostate cancer mortality rates during periods of high but not low statin use in the United States
    Janet L Colli
    Department of Urology, University of Alabama, Birmingham, AL 35294, USA
    Urol Oncol 27:170-3. 2009
  5. ncbi Renal cell carcinoma rates compared with health status and behavior in the United States
    Janet L Colli
    Department of Urology, University of Alabama at Birmingham, 1530 3rd Avenue, South Birmingham, AL 35294, USA
    Urology 73:431-6. 2009
  6. ncbi Chemoprevention of prostate cancer: what can be recommended to patients?
    Janet L Colli
    University of Alabama at Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294, USA
    Curr Urol Rep 10:165-71. 2009
  7. ncbi Bladder cancer incidence and mortality rates compared to ecologic factors among states in America
    Janet L Colli
    University of Alabama, Birmingham, AL, USA
    Int Urol Nephrol 42:659-65. 2010
  8. ncbi Surgical factors affecting return of renal function after partial nephrectomy
    Janet Colli
    VAMC, University of Alabama, Birmingham, AL, USA
    Int Urol Nephrol 43:131-7. 2011
  9. ncbi The effect of prostate cancer screening on stage IV disease in America
    Janet L Colli
    University of Alabama at Birmingham, 1530 3rd Ave South, Birmingham, AL 35294, USA
    Int Urol Nephrol 43:391-6. 2011

Detail Information

Publications9

  1. ncbi Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America
    J L Colli
    Department of Urology, University of Alabama, Birmingham, AL 35294, USA
    Prostate Cancer Prostatic Dis 11:247-51. 2008
    ..We found that prostate cancer mortality rates correlated inversely with urologist population densities (P<0.01) and PSA screening (P<0.01) suggesting that screening and treatment reduce prostate cancer mortality...
  2. ncbi Solar ultraviolet B radiation compared with prostate cancer incidence and mortality rates in United States
    Janet L Colli
    Department of Urology, University of Alabama, Birmingham, School of Medicine, Birmingham, Alabama 35294, USA
    Urology 71:531-5. 2008
    ..Another objective was to explore whether the annual prostate cancer rates correlated more strongly with the cumulative UVB exposure for the year or for exposure during certain seasons...
  3. ncbi Exploring causes for declining prostate cancer mortality rates in the United States
    Janet L Colli
    Department of Urology, University of Alabama, Birmingham, AL 35294, USA Birmingham VA Medical Center VMAC, Birmingham, AL 35294, USA
    Urol Oncol 26:627-33. 2008
    ..The purpose of this study is to compare declining prostate cancer mortality rates among states with independent variables that may have an association to explore causes for the decline...
  4. ncbi High cholesterol levels are associated with reduced prostate cancer mortality rates during periods of high but not low statin use in the United States
    Janet L Colli
    Department of Urology, University of Alabama, Birmingham, AL 35294, USA
    Urol Oncol 27:170-3. 2009
    ..We hypothesize that prostate cancer risks from high cholesterol may be reduced when statin use is high...
  5. ncbi Renal cell carcinoma rates compared with health status and behavior in the United States
    Janet L Colli
    Department of Urology, University of Alabama at Birmingham, 1530 3rd Avenue, South Birmingham, AL 35294, USA
    Urology 73:431-6. 2009
    ..To explore the relationship between renal cell carcinoma rates and health status and behavior in the United States...
  6. ncbi Chemoprevention of prostate cancer: what can be recommended to patients?
    Janet L Colli
    University of Alabama at Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294, USA
    Curr Urol Rep 10:165-71. 2009
    ..The evidence to support prostate cancer risk reduction benefits for each chemoprevention agent based on a review of the literature is provided...
  7. ncbi Bladder cancer incidence and mortality rates compared to ecologic factors among states in America
    Janet L Colli
    University of Alabama, Birmingham, AL, USA
    Int Urol Nephrol 42:659-65. 2010
    ..Smoking, inadequate vitamin D and pesticide exposure have been linked to bladder cancer (BCa) in past studies. The objective of this study is to explore associations between BCa rates and these risk factors...
  8. ncbi Surgical factors affecting return of renal function after partial nephrectomy
    Janet Colli
    VAMC, University of Alabama, Birmingham, AL, USA
    Int Urol Nephrol 43:131-7. 2011
    ..Nephron-sparing surgery is becoming the standard treatment for small renal tumors. In this study, we investigate the relationship between operative factors and recovery of renal function after partial nephrectomy...
  9. ncbi The effect of prostate cancer screening on stage IV disease in America
    Janet L Colli
    University of Alabama at Birmingham, 1530 3rd Ave South, Birmingham, AL 35294, USA
    Int Urol Nephrol 43:391-6. 2011
    ..The study objective is to examine the association between PCa screening and stage IV disease rates in new cases to explore potential benefits for PCa screening...